Heptares and Kymab enter antibody collaboration
18 April 2016 | By Victoria White, Digital Content Producer
Heptares and Kymab are to colllaborate to discover, develop and commercialise novel antibody therapeutics targeting a number of GPCRs...
List view / Grid view
18 April 2016 | By Victoria White, Digital Content Producer
Heptares and Kymab are to colllaborate to discover, develop and commercialise novel antibody therapeutics targeting a number of GPCRs...
15 April 2016 | By Victoria White, Digital Content Producer
An analysis comparing the differences between over 40 strains of Zika virus identified significant changes in both amino acid and nucleotide sequences...
15 April 2016 | By Victoria White, Digital Content Producer
Researchers from MIT and MGH have developed a small, implantable device that delivers chemotherapy drugs directly to pancreatic tumours...
15 April 2016 | By Victoria White, Digital Content Producer
A study suggests that stimulating heat production in brown adipose tissue can improve weight-management and glucose tolerance...
14 April 2016 | By SMi Group
SMi’s 16th annual Pain Therapeutics conference returns to London this May and is thrilled to have Dr Geert Jan Groeneveld, Research Director from the Centre for Human Drug Research, as one of the featured speakers for 2016...
14 April 2016 | By Victoria White, Digital Content Producer
Cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease’s growth and spread, a major new study reports...
14 April 2016 | By Victoria White, Digital Content Producer
Apollo Therapeutics, the investment fund focused on driving therapeutic innovation through university collaboration, has appointed Dr Richard Butt as CEO...
14 April 2016 | By Victoria White, Digital Content Producer
The US Centres for Disease Control and Prevention (CDC) has concluded that Zika virus is a cause of microcephaly and other severe foetal brain defects...
13 April 2016 | By Victoria White, Digital Content Producer
Mathematicians and physicians at the University of Bonn have developed a new model for cancer immunotherapy using mathematics...
13 April 2016 | By Victoria White, Digital Content Producer
The effects of LSD on the human brain have been visualised for the first time and may lead to new treatments for psychiatric disorders...
13 April 2016 | By Victoria White, Digital Content Producer
Sanofi has opened a partnering office at Stevenage Bioscience Catalyst to engage and collaborate with the UK's network of bioscience companies and academia...
12 April 2016 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT...
12 April 2016 | By Victoria White, Digital Content Producer
The result of their research is the production of hundreds of millions of lab-produced human beta cells that are able to relieve diabetes in mice...
12 April 2016 | By Victoria White, Digital Content Producer
Researchers have discovered that interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients...
12 April 2016 | By Victoria White, Digital Content Producer
In addition to the discovery, development and commercialisation of new therapies, the companies will focus on technology development of the CRISPR/Cas platform...